An FDA official told vaccine experts reviewing who should get an additional dose of Pfizer’s Covid-19 vaccine that there isn’t enough data to allow for mixing and matching of different shots
A federal health official said Wednesday there isn’t enough data to support giving a Pfizer Inc. booster dose to people who have received other Covid-19 vaccines.
Doran Fink, a deputy director in the Food and Drug Administration’s vaccines division, made the remarks at a meeting of a key vaccine advisory panel that would recommend who should get
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older.
Lire la suite »
Covid-19: NI records four Covid-linked deaths, 1,060 casesThe total number of deaths linked to coronavirus in NI since the start of the pandemic is 2,517.
Lire la suite »
Johnson & Johnson says COVID-19 booster shot 2 months after first increases protectionThe company has now 'generated evidence that a booster shot further increases protection against Covid-19,' J&J’s chief scientific officer said Tuesday.
Lire la suite »
Pfizer Study of Covid-19 Vaccine in Pregnant Women Delayed by Slow EnrollmentPfizer wanted to study its Covid-19 vaccine in pregnant women, but then the shots became widely available; “It’s hard to enthusiastically recommend the study when you’ve got a vaccine out there,” says one doctor
Lire la suite »
J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decisionJohnson & Johnson became the latest COVID-19 vaccine maker to offer an update on booster doses Tuesday, when it said data from a Phase 3 trial and the real...
Lire la suite »